Stem cell therapy for autoimmune disease is proposed on the reasoning that certain cells may influence immune activity. Autoimmune conditions differ considerably from one another, however, and evidence relevant to one does not transfer to another. The category is too broad to evaluate as a single question.
Ask which specific condition the plan addresses and what evidence relates to it. Ask how the treatment is expected to interact with immunosuppressive or immune-modulating medication, since these are central to managing many autoimmune conditions and are not adjusted lightly.
Your treating specialist should be involved from the outset. Established medication should not be reduced in anticipation of any result, and a clinic suggesting that possibility should be questioned before proceeding. Ask what would be monitored, at what intervals, and what result would justify continuing or stopping the proposed course. Ask also whether the clinic has treated your specific condition before and what it observed, while recognizing that individual reports are not the same as study evidence. Autoimmune conditions differ enough that findings in one rarely transfer directly to another.
